Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test

Journal of Cystic Fibrosis

Volumn 13, Issue 1, 2014, Pages 80-85

  Schmid, Kerstin ^a   Fink, Katharina ^b   Holl, Reinhard W ^b   Hebestreit, Helge ^a   Ballmann, Manfred ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Cystic fibrosis; Cystic fibrosis related diabetes; Oral glucose tolerance test

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; WORLD HEALTH ORGANIZATION;

CYSTIC FIBROSIS; CYSTIC FIBROSIS-RELATED DIABETES; ORAL GLUCOSE TOLERANCE TEST;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; PRACTICE GUIDELINES AS TOPIC; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84890440133     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.06.001     Document Type: Article

References (20)

1. Moran A., Dunitz J., Nathan B., Saeed A., Holme B., Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009, 32:1626-1631.
2. Mohan K., Miller H., Dyce P., Grainger R., Hughes R., Vora J., et al. Mechanisms of glucose intolerance in cystic fibrosis. Diabet Med 2009, 26:582-588.
3. Moran A., Brunzell C., Cohen R.C., Katz M., Marshall B.C., Onady G., et al. Clinical care guidelines for cystic fibrosis-related diabetes. Diabetes Care 2010, 33:2697-2708.
4. Kelly A., Moran A. Update on cystic fibrosis-related diabetes. J Cyst Fibros 2013, 13:119.
5. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications - report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus 1999, World Health Organization, Geneva, [WHO/NCD/NCS/99.2].
6. Mueller-Brandes C., Holl R.W., Nastoll M., Ballmann M. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eur Respir J 2005, 25:715-717.
7. Elder D.A., Wooldridge J.L., Dolan L.M., D'Alessio D.A. Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes. J Pediatr 2007, 151:653-658.
8. Lanng S., Hansen A., Thorsteinsson B., Nerup J., Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995, 311:655-659.
9. Sterescu A.E., Rhodes B., Jackson R., Dupuis A., Hanna A., Wilson D.C., et al. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program. J Pediatr 2010, 156:613-617.
10. Ode K.L., Frohnert B., Laguna T., Phillips J., Holme B., Regelmann W., et al. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes 2010, 11:487-492.
11. Frohnert B.I., Ode K.L., Moran A., Nathan B.M., Laguna T., Holme B., et al. Impaired fasting glucose in cystic fibrosis. Diabetes Care 2010, 33:2660-2664.
12. Tofé S., Moreno J.C., Máiz L., Alonso M., Escobar H., Barrio R. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol 2005, 152(2):241-247.
13. Brodsky J., Dougherty S., Makani R., Rubenstein R.C., Kelly A. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis. Diabetes Care 2011, 34:292-295.
14. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Suppl. 1):S64-S71.
15. World Health Organization Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation 2006, World Health Organization, Geneva, Switzerland.
16. OD́Riordan S.M., Robinson P.D., Donaghue K.C., Moran A. Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes 2009, 12:43-50.
17. Milla C.E., Warwick W.J., Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000, 162:891-895.
18. Lanng S., Thorsteinsson B., Nerup J., Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992, 151:684-687.
19. Hameed S., Morton J.R., Field P.I., Belessis Y., Yoong T., Katz T., et al. Once daily insulin detemir in cystic fibrosis with insulin deficiency. Arch Dis Child 2012, 97:464-467.
20. Bizzarri C., Lucidi V., Ciampalini P., Bella S., Russo B., Cappa M. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. J Endocrinol Invest 2006, 29:RC1-RC4.